WFDC13

WAP four-disulfide core domain 13 Q8IUB5 WFD13_HUMAN
Protein Coding Chr 20 20q13.12 Swiss-Prot reviewed Entrez 164237
Mutations
42
CL 7 · Tissue 35
Samples
42
CL 7 · Tissue 35
Peptides
29
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations42735
Samples42735
Peptides29525

Function

WFDC13 · WAP four-disulfide core domain 13

This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the telomeric cluster. [provided by RefSeq, Jul 2008].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000305479 Q8IUB5 42 29

Gene Properties

Type
Protein Coding
Chromosome
20
Cytoband
20q13.12
Entrez ID
Aliases
C20orf138WAP13dJ601O1.3

Recurrent Mutations

All 29 amino-acid changes on canonical ENST00000305479 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in WFDC13 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in WFDC13 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Melanoma
1/210 0%
13/1899 1%
Squamous Cell Lung Carcinoma
0/57 0%
3/810 0%
Other Solid Cancers
2/94 2%
1/1515 0%
Ovarian Carcinoma
2/109 2%
0/998 0%
Glioma
0/52 0%
4/2127 0%
Head and Neck Carcinoma
0/85 0%
2/1574 0%
Non-Cancerous
0/104 0%
1/830 0%
Gastric Carcinoma
0/74 0%
2/1809 0%
Biliary Tract Carcinoma
0/54 0%
1/950 0%
Bladder Carcinoma
0/58 0%
1/956 0%
Colorectal Carcinoma
1/143 1%
2/3239 0%
Esophageal Squamous Cell Carcinoma
0/51 0%
2/2550 0%
Non-Small Cell Lung Carcinoma
1/304 0%
0/1390 0%
Prostate Carcinoma
0/13 0%
1/2105 0%
Kidney Carcinoma
0/85 0%
1/1862 0%
Other Blood Cancers
0/61 0%
1/2725 0%

Mutation Distribution

Where WFDC13 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in WFDC13 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 30 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 42 mutations in WFDC13

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide